Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
International Psychogeriatrics|September 30, 2005
Rivastigmine in vascular dementiaShoona Vincent, Roger LaneCurrent Alzheimer Research|July 14, 2007
Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesteraseRoger Bullock, Roger LaneNeuroreport|May 16, 2009
Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's diseaseAnnalena Venneri, Roger LaneJournal of Neurology, Neurosurgery, and Psychiatry|March 14, 2007
Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's diseaseHoward H Feldman, Roger Lane, Current Medical Research and Opinion|August 15, 2009
Cholinesterase inhibition: is there evidence for disease-modifying effects?Michael Shanks, Miia Kivipelto, Roger Bullock, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 9, 2007
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's diseaseKolbjorn Bronnick, Murat Emre, Roger Lane, et al.Pharmacogenetics and Genomics|July 21, 2009
Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatmentSteven Ferris, Agneta Nordberg, Hilkka Soininen, et al.Neurology|July 31, 2007
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer diseaseRafael Blesa, Clive Ballard, Jean-Marc Orgogozo, et al.Current Medical Research and Opinion|January 6, 2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathologyJacques Touchon, Howard Bergman, Roger Bullock, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2010
Effects of rivastigmine in Alzheimer's disease patients with and without hallucinationsJeffrey Cummings, Murat Emre, Dag Aarsland, et al.Pageof 4